{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T03:02:11Z","timestamp":1793156531240,"version":"4.5.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T00:00:00Z","timestamp":1765324800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T00:00:00Z","timestamp":1766102400000},"content-version":"vor","delay-in-days":9,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000924","name":"Multiple Sclerosis Australia","doi-asserted-by":"publisher","award":["22-4-097"],"award-info":[{"award-number":["22-4-097"]}],"id":[{"id":"10.13039\/501100000924","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000924","name":"Multiple Sclerosis Australia","doi-asserted-by":"publisher","award":["23-SF-0034"],"award-info":[{"award-number":["23-SF-0034"]}],"id":[{"id":"10.13039\/501100000924","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["2025360"],"award-info":[{"award-number":["2025360"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["2009389"],"award-info":[{"award-number":["2009389"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1175775"],"award-info":[{"award-number":["1175775"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100025520","name":"Medical Research Future Fund","doi-asserted-by":"publisher","award":["EPCD00008"],"award-info":[{"award-number":["EPCD00008"]}],"id":[{"id":"10.13039\/501100025520","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Genome Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Multiple sclerosis (MS) diagnosis relies on identifying disease episodes disseminated in space and time, and excluding other disease explanations. MS is a genetically complex autoimmune and neurodegenerative disorder that shares features with some monogenic progressive neurological conditions. The extent to which people diagnosed with MS have an alternate diagnosis (MS mimic), or genetic multimorbidity is unknown. Additionally, the burden of rare variation associated with MS risk and severity in monogenic neurological disease genes has not been evaluated. We investigated the prevalence of disease-causing variants in progressive neurological disease genes, and their contribution to MS risk and severity, in 4,340 MS cases diagnosed in sub-speciality clinics in Australia and New Zealand, and in 2,861 local controls.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Exome sequencing and array-based genotyping data were analysed for 1,680 genes with pathogenic or likely pathogenic variants reported in ClinVar. Clinical history reviews of MS cases with putative disease-causing variants were conducted. We specifically examined the contribution of rare, likely deleterious variants in a subset of 30 hereditary spastic paraplegia (HSP) genes in 421 individuals with progressive onset MS (POMS). Gene-based association tests with MS risk and severity were performed for all genes in the cohort.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We identified 166 MS cases (3.82%) with variants prompting clinical history reviews, and of 75 cases reviewed, four (0.13% of all cases) had either genetic multimorbidity in addition to MS or a potential misdiagnosis. In contrast to previous findings we observed no enrichment of likely deleterious variants in HSP genes in POMS, nor did we find significant associations between neurological disease genes and MS risk or severity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our findings suggest that rare deleterious genetic variation in progressive neurological disease genes does not play a substantive role in MS risk or severity, and that misdiagnosis is exceedingly rare in this cohort. Consequently, among individuals diagnosed with MS by a specialist, a very small proportion may benefit from clinical genomic testing to inform MS diagnosis or an alternate diagnosis, which could have implications for healthcare management.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13073-025-01582-x","type":"journal-article","created":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T10:37:17Z","timestamp":1765363037000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Rare variation in neurological disease genes and its role in multiple sclerosis mimicry and phenotype"],"prefix":"10.1186","volume":"17","author":[{"given":"Nicholas B.","family":"Blackburn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bennet J.","family":"McComish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan","family":"Motyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James C.","family":"Slimmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Leslie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon A.","family":"Broadley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vilija G.","family":"Jokubaitis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anneke","family":"Van Der Walt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan G.","family":"Kermode","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeannette","family":"Lechner-Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grant P.","family":"Parnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marzena J.","family":"Fabis-Pedrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodney J.","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacey","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicki E.","family":"Maltby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jac C.","family":"Charlesworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn P.","family":"Burdon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce V.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trevor J.","family":"Kilpatrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin P.","family":"Rubio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,10]]},"reference":[{"issue":"4","key":"1582_CR1","doi-asserted-by":"publisher","first-page":"180","DOI":"10.5694\/mja2.51645","volume":"217","author":"BV Taylor","year":"2022","unstructured":"Taylor BV. What causes multiple sclerosis? Getting closer to the answers. Med J Aust. 2022;217(4):180\u20132.","journal-title":"Med J Aust"},{"issue":"2","key":"1582_CR2","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","volume":"17","author":"AJ Thompson","year":"2018","unstructured":"Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2018;17(2):162\u201373.","journal-title":"Lancet Neurol"},{"issue":"12","key":"1582_CR3","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s11910-013-0403-y","volume":"13","author":"AJ Solomon","year":"2013","unstructured":"Solomon AJ, Weinshenker BG. Misdiagnosis of multiple sclerosis: frequency, causes, effects, and prevention. Curr Neurol Neurosci Rep. 2013;13(12):403.","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"24","key":"1582_CR4","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1212\/WNL.0b013e318259e1b2","volume":"78","author":"AJ Solomon","year":"2012","unstructured":"Solomon AJ, Klein EP, Bourdette D. Undiagnosing multiple sclerosis: the challenge of misdiagnosis in MS. Neurology. 2012;78(24):1986\u201391.","journal-title":"Neurology"},{"issue":"8","key":"1582_CR5","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s11910-015-0576-7","volume":"15","author":"M Toledano","year":"2015","unstructured":"Toledano M, Weinshenker BG, Solomon AJ. A clinical approach to the differential diagnosis of multiple sclerosis. Curr Neurol Neurosci Rep. 2015;15(8):57.","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"Pt 3","key":"1582_CR6","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1093\/brain\/awu397","volume":"138","author":"JD Weisfeld-Adams","year":"2015","unstructured":"Weisfeld-Adams JD, Katz Sand IB, Honce JM, Lublin FD. Differential diagnosis of Mendelian and mitochondrial disorders in patients with suspected multiple sclerosis. Brain. 2015;138(Pt 3):517\u201339.","journal-title":"Brain"},{"key":"1582_CR7","doi-asserted-by":"publisher","first-page":"928493","DOI":"10.3389\/fneur.2022.928493","volume":"13","author":"YT Huang","year":"2022","unstructured":"Huang YT, Giacomini PS, Massie R, Venkateswaran S, Trudelle AM, Fadda G, et al. The white matter rounds experience: the importance of a multidisciplinary network to accelerate the diagnostic process for adult patients with rare white matter disorders. Front Neurol. 2022;13:928493.","journal-title":"Front Neurol"},{"key":"1582_CR8","doi-asserted-by":"publisher","unstructured":"Yau WY, Fabis-Pedrini MJ, Kermode AG. Fabry heterozygote mimicking multiple sclerosis. BMJ Case Rep. 2017 Jun 2;2017:bcr2017220274. https:\/\/doi.org\/10.1136\/bcr-2017-220274. PMID: 28576916; PMCID: PMC5534993.","DOI":"10.1136\/bcr-2017-220274"},{"key":"1582_CR9","doi-asserted-by":"publisher","first-page":"860","DOI":"10.3389\/fneur.2020.00860","volume":"11","author":"A Khan","year":"2020","unstructured":"Khan A, Abedi V, Li J, Malik MT, Esch M, Zand R. CADASIL vs. multiple sclerosis: is it misdiagnosis or concomitant? A case series. Front Neurol. 2020;11:860.","journal-title":"Front Neurol"},{"issue":"13 Pt 2","key":"1582_CR10","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1212\/01.wnl.0000304045.99153.8f","volume":"70","author":"BM Keegan","year":"2008","unstructured":"Keegan BM, Giannini C, Parisi JE, Lucchinetti CF, Boeve BF, Josephs KA. Sporadic adult-onset leukoencephalopathy with neuroaxonal spheroids mimicking cerebral MS. Neurology. 2008;70(13 Pt 2):1128\u201333.","journal-title":"Neurology"},{"key":"1582_CR11","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.jns.2017.01.069","volume":"375","author":"A Rubegni","year":"2017","unstructured":"Rubegni A, Battisti C, Tessa A, Cerase A, Doccini S, Malandrini A, et al. SPG2 mimicking multiple sclerosis in a family identified using next generation sequencing. J Neurol Sci. 2017;375:198\u2013202.","journal-title":"J Neurol Sci"},{"issue":"1","key":"1582_CR12","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1002\/ana.25263","volume":"84","author":"X Jia","year":"2018","unstructured":"Jia X, Madireddy L, Caillier S, Santaniello A, Esposito F, Comi G, et al. Genome sequencing uncovers phenocopies in primary progressive multiple sclerosis. Ann Neurol. 2018;84(1):51\u201363.","journal-title":"Ann Neurol"},{"key":"1582_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2020.102302","volume":"44","author":"A Bellinvia","year":"2020","unstructured":"Bellinvia A, Pasto L, Niccolai C, Tessa A, Carrai R, Martinelli C, et al. A new paraplegin mutation in a patient with primary progressive multiple sclerosis. Mult Scler Relat Disord. 2020;44:102302.","journal-title":"Mult Scler Relat Disord"},{"issue":"9","key":"1582_CR14","doi-asserted-by":"publisher","first-page":"5501","DOI":"10.1007\/s10072-022-06145-1","volume":"43","author":"MP Giannoccaro","year":"2022","unstructured":"Giannoccaro MP, Matteo E, Bartiromo F, Tonon C, Santorelli FM, Liguori R, et al. Multiple sclerosis in patients with hereditary spastic paraplegia: a case report and systematic review. Neurol Sci. 2022;43(9):5501\u201311.","journal-title":"Neurol Sci"},{"issue":"3","key":"1582_CR15","volume":"10","author":"JM Mandler","year":"2024","unstructured":"Mandler JM, Hartl J, Cordts I, Sturm M, Hedderich DM, Bafligil C, et al. Uncovering genetic mimics in multiple sclerosis: a single-center clinical exome sequencing study. Mult Scler J. 2024;10(3):20552173241263491.","journal-title":"Mult Scler J"},{"issue":"11","key":"1582_CR16","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1038\/s41588-019-0528-2","volume":"51","author":"AR Martin","year":"2019","unstructured":"Martin AR, Williams E, Foulger RE, Leigh S, Daugherty LC, Niblock O, et al. PanelApp crowdsources expert knowledge to establish consensus diagnostic gene panels. Nat Genet. 2019;51(11):1560\u20135.","journal-title":"Nat Genet"},{"key":"1582_CR17","doi-asserted-by":"crossref","unstructured":"Bellucci G, Buscarinu MC, Renie R, Rinaldi V, Bigi R, Mechelli R et al. Disentangling multiple sclerosis phenotypes through Mendelian disorders: A network approach. Mult Scler J. 2024;30(3):325\u2013335.","DOI":"10.1177\/13524585241227119"},{"issue":"3","key":"1582_CR18","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1002\/ana.410130302","volume":"13","author":"CM Poser","year":"1983","unstructured":"Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol. 1983;13(3):227\u201331.","journal-title":"Ann Neurol"},{"issue":"1","key":"1582_CR19","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1002\/ana.1032","volume":"50","author":"WI McDonald","year":"2001","unstructured":"McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol. 2001;50(1):121\u20137.","journal-title":"Ann Neurol"},{"issue":"12","key":"1582_CR20","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1177\/1352458510379614","volume":"16","author":"BV Taylor","year":"2010","unstructured":"Taylor BV, Pearson JF, Clarke G, Mason DF, Abernethy DA, Willoughby E, et al. MS prevalence in New Zealand, an ethnically and latitudinally diverse country. Mult Scler. 2010;16(12):1422\u201331.","journal-title":"Mult Scler"},{"issue":"6","key":"1582_CR21","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1002\/ana.20703","volume":"58","author":"CH Polman","year":"2005","unstructured":"Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP, Kappos L, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the \u201cMcDonald Criteria.\u201d Ann Neurol. 2005;58(6):840\u20136.","journal-title":"Ann Neurol"},{"issue":"1","key":"1582_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-016-0974-4","volume":"17","author":"W McLaren","year":"2016","unstructured":"McLaren W, Gil L, Hunt SE, Riat HS, Ritchie GR, Thormann A, et al. The Ensembl Variant Effect Predictor. Genome Biol. 2016;17(1):122.","journal-title":"Genome Biol"},{"key":"1582_CR23","doi-asserted-by":"publisher","first-page":"43","DOI":"10.21105\/joss.01686","volume":"4","author":"H Wickham","year":"2019","unstructured":"Wickham H, Averick M, Bryan J, Chang W, McGowan L, Fran\u00e7ois R, et al. Welcome to the tidyverse. J Open Source Softw. 2019;4:43.","journal-title":"J Open Source Softw"},{"issue":"D1","key":"1582_CR24","doi-asserted-by":"publisher","first-page":"D980","DOI":"10.1093\/nar\/gkt1113","volume":"42","author":"MJ Landrum","year":"2014","unstructured":"Landrum MJ, Lee JM, Riley GR, Jang W, Rubinstein WS, Church DM, et al. ClinVar: public archive of relationships among sequence variation and human phenotype. Nucleic Acids Res. 2014;42(D1):D980\u20135.","journal-title":"Nucleic Acids Res"},{"issue":"14","key":"1582_CR25","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1177\/1352458517690618","volume":"23","author":"A Manouchehrinia","year":"2017","unstructured":"Manouchehrinia A, Westerlind H, Kingwell E, Zhu F, Carruthers R, Ramanujam R, et al. Age related multiple sclerosis severity score: disability ranked by age. Mult Scler. 2017;23(14):1938\u201346.","journal-title":"Mult Scler"},{"issue":"2","key":"1582_CR26","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.ajhg.2012.06.007","volume":"91","author":"S Lee","year":"2012","unstructured":"Lee S, Emond MJ, Bamshad MJ, Barnes KC, Rieder MJ, Nickerson DA, et al. Optimal unified approach for rare-variant association testing with application to small-sample case-control whole-exome sequencing studies. Am J Hum Genet. 2012;91(2):224\u201337.","journal-title":"Am J Hum Genet"},{"issue":"7","key":"1582_CR27","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1038\/s41588-021-00870-7","volume":"53","author":"J Mbatchou","year":"2021","unstructured":"Mbatchou J, Barnard L, Backman J, Marcketta A, Kosmicki JA, Ziyatdinov A, et al. Computationally efficient whole-genome regression for quantitative and binary traits. Nat Genet. 2021;53(7):1097\u2013103.","journal-title":"Nat Genet"},{"issue":"6","key":"1582_CR28","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s00439-004-1095-9","volume":"114","author":"JP Rubio","year":"2004","unstructured":"Rubio JP, Bahlo M, Tubridy N, Stankovich J, Burfoot R, Butzkueven H, et al. Extended haplotype analysis in the HLA complex reveals an increased frequency of the HFE-C282Y mutation in individuals with multiple sclerosis. Hum Genet. 2004;114(6):573\u201380.","journal-title":"Hum Genet"},{"issue":"1","key":"1582_CR29","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s13073-023-01199-y","volume":"15","author":"AG Sharo","year":"2023","unstructured":"Sharo AG, Zou Y, Adhikari AN, Brenner SE. ClinVar and HGMD genomic variant classification accuracy has improved over time, as measured by implied disease burden. Genome Med. 2023;15(1):51.","journal-title":"Genome Med"},{"issue":"1","key":"1582_CR30","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s10048-005-0027-8","volume":"7","author":"MA Blair","year":"2006","unstructured":"Blair MA, Ma S, Hedera P. Mutation in KIF5A can also cause adult-onset hereditary spastic paraplegia. Neurogenetics. 2006;7(1):47\u201350.","journal-title":"Neurogenetics"},{"issue":"9","key":"1582_CR31","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1111\/cns.12719","volume":"23","author":"S Chen","year":"2017","unstructured":"Chen S, Ni W, Yin XZ, Liu HQ, Lu C, Zheng QJ, et al. Clinical features and mutation spectrum in Chinese patients with CADASIL: a multicenter retrospective study. CNS Neurosci Ther. 2017;23(9):707\u201316.","journal-title":"CNS Neurosci Ther"},{"issue":"4","key":"1582_CR32","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1056\/NEJM199307223290404","volume":"329","author":"S Tsujino","year":"1993","unstructured":"Tsujino S, Shanske S, DiMauro S. Molecular genetic heterogeneity of myophosphorylase deficiency (McArdle\u2019s disease). N Engl J Med. 1993;329(4):241\u20135.","journal-title":"N Engl J Med"},{"issue":"8","key":"1582_CR33","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/S1474-4422(23)00148-5","volume":"22","author":"AJ Solomon","year":"2023","unstructured":"Solomon AJ, Arrambide G, Brownlee WJ, Flanagan EP, Amato MP, Amezcua L, et al. Differential diagnosis of suspected multiple sclerosis: an updated consensus approach. Lancet Neurol. 2023;22(8):750\u201368.","journal-title":"Lancet Neurol"}],"container-title":["Genome Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13073-025-01582-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13073-025-01582-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13073-025-01582-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T16:23:18Z","timestamp":1781626998000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13073-025-01582-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,10]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1582"],"URL":"https:\/\/doi.org\/10.1186\/s13073-025-01582-x","relation":{},"ISSN":["1756-994X"],"issn-type":[{"value":"1756-994X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,10]]},"assertion":[{"value":"13 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All cases and controls were recruited with written and informed consent, in accordance with the Declaration of Helsinki, and according to the guidelines of local institutional ethics committees as follows: Royal Melbourne Hospital human research ethics committee (HREC) study ID: 2009.040; Life Blood ethics committee study ID: 2006\/2; Alfred Health HREC study ID: 43143; Hunter New England Local Health District HREC study ID: 2019\/ETH12346; Tasmanian HREC study ID: H0009782; Sir Charles Gairdner Hospital HREC study ID: 2006-073 and The University of Western Australia HREC study ID: 2019\/RA\/4\/20\/5859.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"MJF-P has received travel compensation from Merck outside the current work. All other authors declare no competing interests. JLS\u2019s institution receives non-directed funding as well as honoraria for presentations and membership on advisory boards from Biogen, Merck KGaA, Roche and Novartis Australia. JLS is on the steering committee of CLARIFY-MS. JPR has received honoraria for presentations from Biogen.\u00a0Genomic data investigated in this study are the result of a research\u00a0collaboration agreement (RCA) between The Florey Institute of Neuroscience\u00a0and Mental Health and Regeneron Genetics Center\u00ae (RGC\u2122).\u00a0The Florey entered into the RCA on behalf of the Australian and New Zealand MS Genetics Consortium (ANZgene),\u00a0which is comprised of multiple institutions who contributed DNA samples and associated phenotype\u00a0data for the RCA. RGC generated and own the genomic data\u00a0but have provided the means for The Florey to license the genomic data for collaborative, academic research projects.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"149"}}